COVID-19疫苗接种所致锁骨上与腋窝淋巴结病在三种非FDG PET/CT中的表现
Supraclavicular and Axillary Lymphadenopathy Induced by COVID-19 Vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT.
PubMed 文献 · Clin Nucl Med · 2022-01-01
本文报告3例肿瘤患者在接受18F-fluorthanatrace、68Ga-DOTATATE和18F-fluciclovine PET/CT时,出现COVID-19疫苗接种后的反应性淋巴结病。作者强调识别疫苗接种的时间与侧别对避免假阳性判读至关重要。
要点
- COVID-19疫苗接种后可出现反应性淋巴结病,在非FDG PET/CT上也可显示。
- 判读时应结合疫苗接种的时间与注射侧别,避免误判为转移。
- 本文报告3例分别使用18F-fluorthanatrace、68Ga-DOTATATE和18F-fluciclovine的病例。
核心结论
- COVID-19疫苗接种后的反应性淋巴结病可在多种非FDG PET/CT显像中观察到,需结合接种时间与侧别避免假阳性。
研究设计与样本
- 本文为病例报告,呈现3例接受非FDG PET/CT显像患者的疫苗接种后淋巴结病影像表现。
主要发现
- 3例患者分别接受了18F-fluorthanatrace、68Ga-DOTATATE和18F-fluciclovine PET/CT显像。
- 上述显像中可见与COVID-19疫苗接种相关的锁骨上和腋窝反应性淋巴结病。
临床怎么用
- 判读非FDG PET/CT时需询问COVID-19疫苗接种时间与注射侧别,以区分反应性淋巴结与肿瘤病变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
COVID-19 vaccination has started in most countries, and postvaccination imaging is inevitable in the oncologic population. The immune response to the vaccination in the form of reactive lymphadenopathy has been well documented on 18F-FDG PET/CT. We present the imaging findings of 3 patients who have undergone non-FDG PET/CT imaging including 18F-fluorthanatrace, 68Ga-DOTATATE, and 18F-fluciclovine PET/CT. It is crucial to recognize the timing and laterality of immunization to avoid false-positive findings.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Surasi DSS, Lin L, Ravizzini G, et al. Supraclavicular and Axillary Lymphadenopathy Induced by COVID-19 Vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT. Clin Nucl Med. 2022. PMID: 34507331. doi:10.1097/RLU.0000000000003891
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。